| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |